ABSTRACT
OBJECTIVE: To analyze the coverage of lung cancer in Mexico and offer recommendations in this regard. MATERIALS AND METHODS: By means of the conformation of a multidisciplinary group, we analyze the burden of the disease relative to the lung cancer and the access to the medical treatment offered by the different public health subsystems in Mexico. RESULTS: Important inequalities in lung cancer care are documented among the different public health subsystems. Our data suggest differential access and coverage to both traditional treatments and existing therapeutic innovations and differences in the capacity of health service providers to guarantee the right to health protection without distinction. CONCLUSIONS: Recommendations are made on the need to improve actions for tobacco control, early diagnosis for lung cancer and inclusion of innovative therapies and homologation among different public health service providers through financing via tobacco taxes.
OBJETIVO: Analizar la cobertura en salud de cáncer pulmonar en México y ofrecer recomendaciones al respecto. MATERIAL Y MÉTODOS: Mediante la conformación de un grupo multidisciplinario se analizó la carga de la enfermedad relativa al cáncer de pulmón y el acceso al tratamiento médico que ofrecen los diferentes subsistemas de salud en México. RESULTADOS: Se documentan desigualdades importantes en la atención del cáncer de pulmón entre los distintos subsistemas de salud que sugieren acceso y cobertura en salud variable, tanto a los tratamientos tradicionales como a las innovaciones terapéuticas existentes, y diferencias en la capacidad de los prestadores de servicios de salud para garantizar el derecho a la protección de la salud sin distinciones. CONCLUSIONES: Se hacen recomendaciones sobre la necesidad de mejorar las acciones para el control del tabaco, el diagnóstico temprano y la inclusión de terapias innovadoras y la homologación entre los diferentes prestadores públicos de servicios de salud a través del financiamiento con la recaudación de impuestos al tabaco.
Subject(s)
Health Services Accessibility , Health Services Needs and Demand , Lung Neoplasms/therapy , Adolescent , Adult , Aged , Female , Humans , Male , Mexico , Middle Aged , Public Health , Young AdultABSTRACT
Resumen: Objetivo: Analizar la cobertura en salud de cáncer pulmonar en México y ofrecer recomendaciones al respecto. Material y métodos: Mediante la conformación de un grupo multidisciplinario se analizó la carga de la enfermedad relativa al cáncer de pulmón y el acceso al tratamiento médico que ofrecen los diferentes subsistemas de salud en México. Resultados: Se documentan desigualdades importantes en la atención del cáncer de pulmón entre los distintos subsistemas de salud que sugieren acceso y cobertura en salud variable, tanto a los tratamientos tradicionales como a las innovaciones terapéuticas existentes, y diferencias en la capacidad de los prestadores de servicios de salud para garantizar el derecho a la protección de la salud sin distinciones. Conclusión: Se hacen recomendaciones sobre la necesidad de mejorar las acciones para el control del tabaco, el diagnóstico temprano y la inclusión de terapias innovadoras y la homologación entre los diferentes prestadores públicos de servicios de salud a través del financiamiento con la recaudación de impuestos al tabaco.
Abstract: Objective: To analyze the coverage of lung cancer in Mexico and offer recommendations in this regard. Materials and methods: By means of the conformation of a multidisciplinary group, we analyze the burden of the disease relative to the lung cancer and the access to the medical treatment offered by the different public health subsystems in Mexico. Results: Important inequalities in lung cancer care are documented among the different public health subsystems. Our data suggest differential access and coverage to both traditional treatments and existing therapeutic innovations and differences in the capacity of health service providers to guarantee the right to health protection without distinction. Conclusions: Recommendations are made on the need to improve actions for tobacco control, early diagnosis for lung cancer and inclusion of innovative therapies and homologation among different public health service providers through financing via tobacco taxes.
Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Aged , Young Adult , Health Services Accessibility , Health Services Needs and Demand , Lung Neoplasms/therapy , Public Health , MexicoABSTRACT
Resumen
El Cyberknife es un sistema de radiocirugía robótica sin marco de fijación, utilizado para tratar tumores benignos, tumores malignos y otras condiciones médicas. El sistema consiste en un método para administrar radiación ionizante con el acelerador lineal en forma localizada y con mayor precisión que con la radioterapia convencional. Como personal ocupacionalmente expuesto (POE), la enfermera debe ejercer todas sus funciones en los servicios y unidades donde se utilizan radiaciones ionizantes con fines médicos; por lo tanto, trabaja en estricta colaboración con el médico radiooncólogo, el físico, el dosimetrista y el técnico de radioterapia, ya que provee los cuidados específicos al paciente en la exploración y el tratamiento.
Abstract
The Cyberknife is a robotic radiosurgery system with no fixation frame, used to treat benign tumors, malignant tumors and other medical conditions. The system consists of a method for administering ionizing radiation with the linear accelerator in a localized form and with greater accuracy than with conventional radiotherapy. As an Occupationally Exposed Personnel (NPO), the nurse must perform all her functions in the services and units where medical ionizing radiation is used; therefore, it works in strict collaboration with the radiologist, the physicist, the medical dosimetrist and the radiotherapy technician, since it provides the specific care to the patient in the exploration and treatment.
Subject(s)
Humans , Nursing, Practical , Neoplasms , Radiation, Ionizing , Radiosurgery , Robotics , Mexico , HumansABSTRACT
UNLABELLED: Objetive: To analyze cancer mortality in affiliates of the Mexican Social Security Institute (Instituto Mexicano del Seguro Social - IMSS) and time trends in the risk of death due to cancer from 1989 to 2013. MATERIALS AND METHODS: A descriptive analysis of cancer mortality trends in beneficiaries of the IMSS was performed. Age- and sex-adjusted mortality rates were obtained using direct standardization with the WHO population. Changes in the risk of death due to cancer over time were evaluated using Poisson regression. RESULTS: The absolute number of deaths due to cancer doubled from 1989 to 2013 due to increasing age of the affiliate population. The risk of death among affiliates decreased for the majority of cancers except for colon and rectal cancer. CONCLUSION: The risk of dying from cancer among IMSS affiliates showed a marked decrease, which may be due to an increase in detection and opportune treatment.
Subject(s)
Neoplasms/mortality , Social Security/statistics & numerical data , Academies and Institutes/statistics & numerical data , Adolescent , Adult , Aged , Child , Child, Preschool , Female , Geography, Medical , Humans , Infant , Male , Mexico/epidemiology , Middle Aged , Mortality/trends , Retrospective Studies , Young AdultABSTRACT
Chronic noncommunicable diseases (NCDs), including cancer, have become the leading cause of human morbidity and mortality. In Mexico, cancer is the third leading cause of death, with a high incidence among the economically active population, a high proportion of advanced stages at diagnosis and limited care coverage for patients. However, no public policy aimed at managing this important public health problem has been developed and implemented to date. This manuscript describes the first interinstitutional proposal of a National Program for Cancer Control, considering the known risk factors, early detection, treatment, palliative care and patient rehabilitation. This manuscript also outlines a series of thoughts on the difficulties and needs that the Mexican health system faces in achieving the main objectives of the program: to decrease the incidence of cancer, to increase survival and to improve the quality of life for this group of patients.
Subject(s)
Delivery of Health Care/trends , National Health Programs/trends , Neoplasms/prevention & control , Cancer Care Facilities/classification , Cancer Care Facilities/organization & administration , Disease Management , Early Detection of Cancer , Health Policy , Humans , Incidence , Mexico/epidemiology , National Health Programs/organization & administration , Neoplasms/diagnosis , Neoplasms/epidemiology , Neoplasms/therapy , Palliative Care , Primary Prevention/organization & administration , Quality of Life , Risk FactorsABSTRACT
Abstract Objetive: To analyze cancer mortality in affiliates of the Mexican Social Security Institute (Instituto Mexicano del Seguro Social - IMSS) and time trends in the risk of death due to cancer from 1989 to 2013. Materials and Methods: A descriptive analysis of cancer mortality trends in beneficiaries of the IMSS was performed. Age- and sex-adjusted mortality rates were obtained using direct standardization with the WHO population. Changes in the risk of death due to cancer over time were evaluated using Poisson regression. Results: The absolute number of deaths due to cancer doubled from 1989 to 2013 due to increasing age of the affiliate population. The risk of death among affiliates decreased for the majority of cancers except for colon and rectal cancer. Conclusion: The risk of dying from cancer among IMSS affiliates showed a marked decrease, which may be due to an increase in detection and opportune treatment.
Resumen Objetivo: Analizar la frecuencia de las defunciones por cáncer en la población derechohabiente (DH) del Instituto Mexicano del Seguro Social, así como la tendencia temporal en el riesgo de muerte por esta causa de 1989 a 2013. Material y métodos: Se realizó análisis descriptivo del comportamiento de la mortalidad por cáncer en población derechohabiente del IMSS. Las tasas de mortalidad ajustadas por edad y sexo se obtuvieron con el método directo utilizando la población mundial estándar de la OMS. Los cambios en el riesgo de morir por cáncer a través del tiempo se evaluaron mediante regresión de Poisson. Resultados: El número absoluto de defunciones por cáncer se duplicó de1989 a 2013 debido a un aumento y al envejecimiento de la población derechohabiente. El riesgo de muerte en los DH disminuyó para la mayoría de los diferentes tipos de cáncer, excepto para el cáncer de colon y recto. Conclusión: El riesgo de morir por cáncer en DH del IMSS muestra una discreta disminución, posiblemente debido a la mejora en la detección y tratamiento oportuno.
Subject(s)
Humans , Male , Female , Infant , Child, Preschool , Child , Adolescent , Adult , Middle Aged , Young Adult , Social Security/statistics & numerical data , Neoplasms/mortality , Retrospective Studies , Mortality/trends , Academies and Institutes/statistics & numerical data , Geography, Medical , Mexico/epidemiologyABSTRACT
Abstract Chronic noncommunicable diseases (NCDs), including cancer, have become the leading cause of human morbidity and mortality. In Mexico, cancer is the third leading cause of death, with a high incidence among the economically active population, a high proportion of advanced stages at diagnosis and limited care coverage for patients. However, no public policy aimed at managing this important public health problem has been developed and implemented to date. This manuscript describes the first interinstitutional proposal of a National Program for Cancer Control, considering the known risk factors, early detection, treatment, palliative care and patient rehabilitation. This manuscript also outlines a series of thoughts on the difficulties and needs that the Mexican health system faces in achieving the main objectives of the program: to decrease the incidence of cancer, to increase survival and to improve the quality of life for this group of patients.
Resumen Las enfermedades crónicas no transmisibles (ECNT), incluido el cáncer, se han convertido en la principal causa de morbimortalidad de la humanidad. En México, el cáncer es la tercera causa de muerte, con una frecuencia elevada en población económicamente activa, una alta proporción de etapas avanzadas al momento del diagnóstico y una limitada cobertura de atención a quienes la padecen. No obstante, hasta el momento no se ha desarrollado e implementado una política pública dirigida al control de este importante problema de salud pública. Este manuscrito muestra la primera propuesta interinstitucional de un Programa Nacional para el Control del Cáncer, considerando los factores de riesgo conocidos, la detección temprana, el tratamiento y los cuidados paliativos y la rehabilitación del paciente. Asimismo se hacen una serie de reflexiones sobre las dificultades y necesidades a las que el sistema de salud mexicano se enfrenta para alcanzar los objetivos principales del programa: reducir la incidencia, incrementar la supervivencia y mejorar la calidad de vida de este grupo de pacientes.
Subject(s)
Humans , Delivery of Health Care/trends , National Health Programs/trends , Neoplasms/prevention & control , Palliative Care , Primary Prevention/organization & administration , Quality of Life , Cancer Care Facilities/classification , Cancer Care Facilities/organization & administration , Incidence , Risk Factors , Disease Management , Early Detection of Cancer , Health Policy , Mexico/epidemiology , National Health Programs/organization & administration , Neoplasms/diagnosis , Neoplasms/therapy , Neoplasms/epidemiologyABSTRACT
OBJECTIVE: to value diagnostic stage and direct costs due to cervical cancer in insured workers and IMSS beneficiaries patients, during first year of treatment. METHODS: 80 records of patients with confirmed diagnosis of cervical cancer during 2000-2003 were analyzed. The study was made under provider public health services perspective, with focus in costs incidence during 2009. RESULTS: 27 (34 %) of total records corresponding to insured worker and 53 (66 %) to beneficiaries. No differences were finding in diagnostic stage. In bout groups stage II was the most common. The cost due medical care adds up to $91,064.00 during first year of treatment in workers. The main costs were identified in sickness absence certification (31 %), image exams (24 %) consulting room (19 %), radiotherapy sessions (10 %) and hospitalization (9 %). CONCLUSIONS: cervical cancer is a frequent disease that affects women in their productive and reproductive age. Frequently their diagnosis is made in advanced stages, which increase medical attention cost. It is convenient to introduce more effective preventive actions, including the workplace.
Subject(s)
Health Care Costs , Uterine Cervical Neoplasms/economics , Adult , Aged , Aged, 80 and over , Cross-Sectional Studies , Female , Humans , Middle Aged , Uterine Cervical Neoplasms/diagnosis , Uterine Cervical Neoplasms/therapyABSTRACT
BACKGROUND: Attitude changing involves a holistic change on individual biopsychosocial structure. That attitude is understood by behaviors, thoughts, feelings and higher mental processes involved with behavior. This attitude will be considered in two ways: favorable or unfavorable, through a part of the environment. If unfavorable, the most common way to change it is through teaching and learning processes. The aim of this study was to evaluate the impact of a program directed to modify cancer patients' attitudes. METHODS: This study was performed in three stages from February to September 2009 in the Medical Oncology Area of the UMAE Oncology Hospital, Instituto Mexicano del Seguro Social (IMSS), according to a before and after quasi-experimental design to evaluate the effect of the intervention. The first stage was to diagnose through semantic networks using the results to create and validate a survey. The second stage was the educative intervention focused on providing general information to patients in the area of medical oncology. Finally, the initial survey was used in order to measure the impact of the intervention, which had been previously implemented and validated. The cumulative total of patients during the three stages was 4,200. RESULTS: Patients attitudes were modified with a specific favorable tendency on the instrument from 51% to 94% (p = 0.05) of total instrument perceptions. CONCLUSIONS: This intervention significantly changed patients' attitudes related to the medical oncology area.
Subject(s)
Attitude to Health , Neoplasms/psychology , Oncology Service, Hospital/statistics & numerical data , Patient Education as Topic/organization & administration , Patients/psychology , Persuasive Communication , Academies and Institutes , Data Collection , Humans , Mexico , Neoplasms/therapy , Patient Acceptance of Health Care , Patient Satisfaction , Physician-Patient Relations , Program Evaluation , Semantics , Social Perception , Social SecurityABSTRACT
INTRODUCTION: Ovarian cancer (OC) is the third most common gynecologic malignancy worldwide. Most of cases it is of epithelial origin. At the present time there is not a standardized screening method, which makes difficult the early diagnosis. The 5-year survival is 90% for early stages, however most cases present at advanced stages, which have a 5-year survival of only 5-20%. GICOM collaborative group, under the auspice of different institutions, have made the following consensus in order to make recommendations for the diagnosis and management regarding to this neoplasia. MATERIAL AND METHODS: The following recommendations were made by independent professionals in the field of Gynecologic Oncology, questions and statements were based on a comprehensive and systematic review of literature. It took place in the context of a meeting of two days in which a debate was held. These statements are the conclusions reached by agreement of the participant members. RESULTS: No screening method is recommended at the time for the detection of early lesions of ovarian cancer in general population. Staging is surgical, according to FIGO. In regards to the pre-surgery evaluation of the patient, it is recommended to perform chest radiography and CT scan of abdomen and pelvis with IV contrast. According to the histopathology of the tumor, in order to consider it as borderline, the minimum percentage of proliferative component must be 10% of tumor's surface. The recommended standardized treatment includes primary surgery for diagnosis, staging and cytoreduction, followed by adjuvant chemotherapy Surgery must be performed by an Oncologist Gynecologist or an Oncologist Surgeon because inadequate surgery performed by another specialist has been reported in 75% of cases. In regards to surgery it is recommended to perform total omentectomy since subclinic metastasis have been documented in 10-30% of all cases, and systematic limphadenectomy, necessary to be able to obtain an adequate surgical staging. Fertility-sparing surgery will be performed in certain cases, the procedure should include a detailed inspection of the contralateral ovary and also negative for malignancy omentum and ovary biopsy. Until now, laparoscopy for diagnostic-staging surgery is not well known as a recommended method. The recommended chemotherapy is based on platin and taxanes for 6 cycles, except in Stage IA, IB and grade 1, which have a good prognosis. In advanced stages, primary cytoreduction is recommended as initial treatment. Minimal invasion surgery is not a recommended procedure for the treatment of advanced ovarian cancer. Radiotherapy can be used to palliate symptoms. Follow up of the patients every 2-4 months for 2 years, every 3-6 months for 3 years and anually after the 5th year is recommended. Evaluation of quality of life of the patient must be done periodically. CONCLUSIONS: In the present, there is not a standardized screening method. Diagnosis in early stages means a better survival. Standardized treatment includes primary surgery with the objective to perform an optimal cytoreduction followed by chemotherapy Treatment must be individualized according to each patient. Radiotherapy can be indicated to palliate symptoms.
Subject(s)
Ovarian Neoplasms , Aftercare , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Chemotherapy, Adjuvant , Combined Modality Therapy , Drug Resistance, Neoplasm , Early Diagnosis , Female , Genes, Neoplasm , Humans , Laparoscopy , Lymph Node Excision , Neoadjuvant Therapy , Neoplasm Staging/standards , Neoplastic Syndromes, Hereditary/genetics , Omentum/surgery , Organoplatinum Compounds/administration & dosage , Ovarian Neoplasms/diagnosis , Ovarian Neoplasms/epidemiology , Ovarian Neoplasms/genetics , Ovarian Neoplasms/pathology , Ovarian Neoplasms/therapy , Ovariectomy/methods , Palliative Care , Quality of Life , Radiotherapy, Adjuvant , Salvage Therapy , Taxoids/administration & dosageABSTRACT
INTRODUCTION: Endometrial cancer (EC) is the second most common gynecologic malignancy worldwide in the peri and postmenopausal period. Most often for the endometrioid variety. In early clinical stages long-term survival is greater than 80%, while in advanced stages it is less than 50%. In our country there is not a standard management between institutions. GICOM collaborative group under the auspice of different institutions have made the following consensus in order to make recommendations for the management of patients with this type of neoplasm. MATERIAL AND METHODS: The following recommendations were made by independent professionals in the field of Gynecologic Oncology, questions and statements were based on a comprehensive and systematic review of literature. It took place in the context of a meeting of four days in which a debate was held. These statements are the conclusions reached by agreement of the participant members. RESULTS: Screening should be performed women at high risk (diabetics, family history of inherited colon cancer, Lynch S. type II). Endometrial thickness in postmenopausal patients is best evaluated by transvaginal US, a thickness greater than or equal to 5 mm must be evaluated. Women taking tamoxifen should be monitored using this method. Abnormal bleeding in the usual main symptom, all post menopausal women with vaginal bleeding should be evaluated. Diagnosis is made by histerescopy-guided biopsy. Magnetic resonance is the best image method as preoperative evaluation. Frozen section evaluates histologic grade, myometrial invasion, cervical and adnexal involvement. Total abdominal hysterectomy, bilateral salpingo oophorectomy, pelvic and para-aortic lymphadenectomy should be performed except in endometrial histology grades 1 and 2, less than 50% invasion of the myometrium without evidence of disease out of the uterus. Omentectomy should be done in histologies other than endometriod. Surgery should be always performed by a Gynecologic Oncologist or Surgical Oncologist, laparoscopy is an alternative, especially in patients with hypertension and diabetes for being less morbid. Adjuvant treatment after surgery includes radiation therapy to the pelvis, brachytherapy, and chemotherapy. Patients with Stages III and IV should have surgery with intention to achieve optimal cytoreduction because of the impact on survival (51 m vs. 14 m), the treatment of recurrence can be with surgery depending on the pattern of relapse, systemic chemotherapy or hormonal therapy. Follow-up of patients is basically clinical in a regular basis. CONCLUSIONS: Screening programme is only for high risk patients. Multidisciplinary treatment impacts on survival and local control of the disease, including surgery, radiation therapy and chemotherapy, hormonal treatment is reserved to selected cases of recurrence. This is the first attempt of a Mexican Collaborative Group in Gynecology to give recommendations is a special type of neoplasm.
Subject(s)
Carcinoma , Endometrial Neoplasms , Antineoplastic Agents/therapeutic use , Carcinoma/diagnosis , Carcinoma/epidemiology , Carcinoma/pathology , Carcinoma/therapy , Chemotherapy, Adjuvant , Combined Modality Therapy , Diagnostic Imaging , Endometrial Neoplasms/diagnosis , Endometrial Neoplasms/epidemiology , Endometrial Neoplasms/pathology , Endometrial Neoplasms/therapy , Estrogen Antagonists/adverse effects , Estrogen Replacement Therapy/adverse effects , Estrogens/adverse effects , Evidence-Based Medicine , Female , Humans , Hysterectomy/methods , Laparoscopy , Lymph Node Excision , Mass Screening , Mexico , Neoplasm Staging/methods , Radiotherapy, Adjuvant , Risk Factors , Salvage Therapy , Tamoxifen/adverse effectsABSTRACT
OBJECTIVE: To identify the associated factors for non-compliance among women for the cervical cancer screening program. METHODS: A case-control study was carried out in which cases were women who were just diagnosed with cervical cancer (confirmed with pathological study); controls were women not having cervical cancer (negative pathological study). Cases and controls had the same age, lived in the same geographical area and were selected from the primary care facilities. Lack of compliance for cervical cancer screening was defined as the time since the last cytology (no previous Pap test or > or =3 years since last Pap test). A logistic regression analysis served to identify the associated factors to the lack of compliance. RESULTS: There were 279 cases and 392 controls included in the study. The rate of non-compliance among cases was 76.7% and among controls was 29.6%. Among cases 45.5% had never undergone Pap test compared with 9.9% of controls. Main risk factors for non-compliance to attend to cervical cancer screening were age > 65 years (aOR = 2.9, 95% CI 1.6-5-3); illiteracy (aOR = 3.8, 95% CI 1.7-6); use of public transportation to attend to the preventive service (aOR = 2.3, 95% CI 1.2-6.4); more than five pregnancies (aOR = 3.0, 95% CI 1.6-5.3) and lack of knowledge about cervical cancer (aOR = 4.2, 95% CI 3.6-7.2). CONCLUSION: The rate of non-compliance close to 30% was high; social and cultural risk factors were the most relevant.
Subject(s)
Treatment Refusal/statistics & numerical data , Uterine Cervical Neoplasms/pathology , Vaginal Smears/statistics & numerical data , Adult , Aged , Case-Control Studies , Female , Humans , Middle Aged , Risk FactorsABSTRACT
INTRODUCTION: Laparoscopic hysterectomy (LH) is a safe surgical approach that offers patients a faster recovery. However, its use in malignant or premalignant gynecological lesions is not well established. The objective of the present study was to show the feasibility of LH in a tertiary cancer center. MATERIAL AND METHODS: We conducted a descriptive analysis of patients with histologically proven malignant or premalignant uterine lesions who underwent to LH. Surgical time, bleeding complications, and hospital stay were evaluated. RESULTS: Twenty-five patients were included with a mean age of 45 years. Ten LH (40%) with or without salpingo-oophorectomy for premalignant or preinvasive malignant lesions were done, five surgical staging procedures for endometrial cancer (20%) and seven radical hysterectomies for cervical cancer (28%). In three patients, conversion from laparotomy (12%) was necessary for operative complications (two cases) or technical problems (one case). Mean operative time for the entire group was 207 min, mean bleeding 204 mL and mean hospital stay was 2.5 days. Postoperative complications were present in two patients, hematoma in the vaginal cupola (one case) and temporary bladder dysfunction (one case). CONCLUSIONS: In the present trial we described our initial experience in LH for the treatment of malignant and premalignant gynecologic diseases. Our results suggest that it is a safe and feasible surgical approach. Long-term surveillance studies are necessary for the evaluation of recurrence patterns and overall survival.
Subject(s)
Hysterectomy , Laparoscopy , Precancerous Conditions/surgery , Uterine Cervical Neoplasms/surgery , Uterine Neoplasms/surgery , Adult , Aged , Feasibility Studies , Female , Humans , Laparotomy , Length of Stay , Middle Aged , Ovariectomy , Salpingostomy , Time FactorsABSTRACT
BACKGROUND: Variations in the incidence of cancer can be influenced by diet and specific lifestyles. In the last years, diet has been evaluated as an important factor in the development of ovarian cancer, even though the results have not been consistent. Dietary factors related to the risk of ovarian cancer in Mexican women were evaluated. METHODS: A case-control study in Mexico City was done during 1995-1997 in a social security hospital, evaluating 84 new cases of ovarian cancer and 629 controls. A validated questionnaire with 116 items about the frequency and type of food intake was used. The analysis of nutrients was done with the residual method adjusted for total energy intake and other predictor variables through logistic regression methods. Also, partition models estimated the total caloric intake for other sources. RESULTS: The nutrients negatively associated with ovarian cancer in the highest versus the lowest tertile were retinol (OR 0.52; p for trend = 0.03) and vitamin D (OR 0.43; 95% CI 0.23-0.80; p = 0.01; residual model). Additionally, carbohydrates were positively associated (partition model: OR 1.08; 95% CI 1.00-1.15), and tortilla intake did not show an association with ovarian cancer (OR 0.96; 95% CI 0.78-1.17). CONCLUSIONS: The diet of the Mexican population is rich in carbohydrates; in Mexico corn intake is the main energy source. On the other hand, vitamins such as retinol and vitamin D were shown to be associated with this neoplasm in a protective way; nevertheless, further studies are necessary to allow us to corroborate our results. This is the first attempt in our country that relates the Mexican diet to ovarian cancer.
Subject(s)
Nutritional Physiological Phenomena , Ovarian Neoplasms/epidemiology , Risk Factors , Adult , Aged , Animals , Case-Control Studies , Dietary Carbohydrates/adverse effects , Dietary Fats , Dietary Fats, Unsaturated , Dietary Proteins , Energy Intake , Female , Fruit , Humans , Incidence , Meat , Mexico/epidemiology , Middle Aged , Surveys and Questionnaires , Vegetables , Vitamin A , Vitamin DABSTRACT
Se revisaron retrospectivamente 63 pacientes con diagnóstico de carcinoma microinvasor de cervix. La metodología diagnóstica incluyó: citología, colposcopia, biopsia y cono cervical. Los parámetros de estudio fueron: edad, síntomas, tipo de tratamiento y supervivencia. De acuerdo a los factores pronósticos adversos tales como profundidad de invasión, permeación linfovascular, patrón de invasión, se elegía el tratamiento a seguír. Las pacientes con profundidad de invasión hasta 1 mm (IA1, FIGO) pueden ser tratadas conservadoramente mediante cono cervical si requieren conservar su fertilidad ya que existe de metástasis y/o recurrencia en este grupo. Las pacientes con invasión de 1 a 5 mm (IA2, FIGO) parecen tener mayor riesgo de recurrencia y enfermedad ganglionar y aún si el tratamiento debe ser individualizado. No existen datos colposcópicos específicos de microcarcinoma, por lo que la precisión diagnóstica no es alta; sin embargo la colposcopia indica el sitio de la toma adecuada de la biopsia, identifica áreas de extensión vaginal y puede influir en el tratamiento
